Combination of PARP inhibitor olaparib, and PD-L1 inhibitor durvalumab, in recurrent ovarian cancer: a proof-of-concept phase 2 study
| Image |  |
|---|---|
| Description | scientific article published on 12 May 2020 |
| Author/s |
author: Mohammadhadi Bagheri Erika J Lampert Stanley Lipkowitz Ashley Cimino-Mathews James W Hodge Alexandra S Zimmer Andrew B Nixon Elizabeth M Swisher |
| Publication date | May 12, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |